Onesource Specialty Pharma
add_icon

Onesource Specialty Pharma

1,701.80
+67.40
(4.12%)
Market Cap
₹19,489.90 Cr
PE Ratio
472.59
Volume
7,97,224.00
Day High - Low
₹1,712.50 - ₹1,634.30
52W High-Low
₹2,248.00 - ₹1,209.95
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
19,489.90 Cr
EPS
-1.63
PB Ratio
3.20
Book Value
515.29
EBITDA
484.00
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
-0.29
Debt to Equity
0.21
Analyst Rating and Forecast
- By Refinitiv from4 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Tenshi Pharmaceuticals pledged 20 lakh equity shares of Onesource Specialty Pharma on December 16, 2025, citing business and operational requirements under SEBI disclosure norms.
neutral
OneSource Specialty Pharma Allots 23,000 Equity Shares Under Employee Stock Option Plan9 days ago
OneSource Specialty Pharma's Management Committee allotted 23,000 equity shares of INR 1 each to eligible employees under the ONESOURCE ESOP 2021 plan at a premium of INR 277 per share. The allotment increased the company's paid-up share capital from INR 11,45,62,136 to INR 11,45,85,136, with the new shares ranking pari passu with existing equity shares.
negative
OneSource Specialty Pharma delivered 12% revenue growth to INR 3,758 million and 37% EBITDA growth to INR 1,065 million in Q2 FY26, with margins expanding 506 basis points to 28%. The company faces near-term revenue recognition uncertainty due to regulatory approval delays for GLP-1 customers including potential Canada launch delays, while maintaining confidence in FY28 guidance of INR 500 million revenue including proposed acquisitions.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,745.10
#1 4,18,707.95
39.94
#1 54,729.00
9.71
#1 10,980
2.89
42.79
6,472.00
1,71,811.26
68.16
9,712.00
18.67
2,191
35.10
47.58
3,797.70
1,28,531.42
59.46
11,539.40
6.99
1,911
30.46
52.82
1,517.10
1,22,544.37
22.28
28,409.50
7.12
5,291
3.71
43.51
1,277.20
1,06,596.87
18.62
33,741.20
16.73
5,725
-0.38
58.95
2,124.50
97,037.50
22.26
22,909.50
13.74
3,306
#1 72.75
64.02
919.85
92,558.43
#1 18.28
23,511.00
18.55
4,615
34.60
36.05
2,171.00
89,609.87
49.87
12,744.20
#1 20.90
2,007
-21.05
35.33
1,225.00
71,148.20
20.54
32,345.60
9.43
3,484
3.81
56.28
5,551.00
66,370.53
27.37
13,458.30
3.70
2,216
10.98
39.60
Growth Rate
Revenue Growth
730.38 %
Net Income Growth
-95.27 %
Cash Flow Change
36.71 %
ROE
-99.69 %
ROCE
-103.78 %
EBITDA Margin (Avg.)
-169.39 %

Quarterly Financial Results

Quarterly Financials
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
10
34
88
76
296
338
399
429
333
379
Expenses
80
105
173
76
233
263
351
244
242
269
EBITDA
-70
-71
-85
-0
64
76
48
185
91
110
Operating Profit %
-800 %
-210 %
-207 %
-4 %
20 %
21 %
11 %
43 %
26 %
28 %
Depreciation
19
18
20
20
68
68
69
69
68
70
Interest
18
25
26
21
42
45
46
33
28
34
Profit Before Tax
-107
-114
-130
-40
-47
-38
-67
83
-4
6
Tax
0
0
0
0
-41
5
2
-16
-4
-5
Net Profit
-107
-114
-130
-40
-6
-42
-69
99
-0
11
EPS in ₹
0.00
-27.37
-31.32
-9.67
-0.51
-10.13
-6.31
8.61
-0.02
0.92

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
1,258
2,442
2,009
1,309
7,550
Fixed Assets
633
1,231
1,361
863
6,118
Current Assets
99
511
228
176
1,086
Capital Work in Progress
431
490
335
188
218
Investments
0
0
5
20
16
Other Assets
195
722
309
238
1,199
Total Liabilities
1,258
2,442
2,009
1,309
7,550
Current Liabilities
161
809
865
631
1,114
Non Current Liabilities
321
621
358
282
556
Total Equity
776
1,013
786
396
5,881
Reserve & Surplus
775
1,009
781
392
5,869
Share Capital
2
3
4
4
11

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
Net Cash Flow
56
55
-112
13
143
Investing Activities
-207
-692
-68
511
-201
Operating Activities
-118
-416
-163
-107
-68
Financing Activities
381
1,162
118
-391
412

Share Holding

% Holding
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
37.77 %
34.25 %
29.79 %
29.77 %
FIIs
17.44 %
18.54 %
18.69 %
19.39 %
DIIs
12.56 %
18.04 %
18.10 %
18.49 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
13.05 %
12.50 %
13.25 %
12.42 %
Others
19.18 %
16.67 %
20.17 %
19.93 %
No of Share Holders
98,425
82,712
87,760
87,416

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
14 Feb 2024 CHANGE OF NAME Change Of Name
NA
14 Feb 2024 0.00 0.00
29 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Jan 2025 0.00 1,536.60
05 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 May 2025 1,593.85 1,593.00
04 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Aug 2025 1,995.05 1,847.80
22 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
22 Sept 2025 1,855.40 1,836.20
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2025 1,825.85 1,790.90

Announcements

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.4 hours ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS8 days ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS9 days ago
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 18, 2025
Update On Non-Participation Of The Representatives Of The Company In The Jefferies ConferenceNov 18, 2025
General UpdatesNov 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 13, 2025
Investor PresentationNov 12, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 11, 2025
Financial Results For The Quarter And Half Year Ended September 30 2025.Nov 11, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 11/11/2025 To Approve The Financial Results For The Quarter And Half Year Ended September 30 2025.Nov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 05, 2025
Board Meeting Intimation for Approving The Financial Results For The Quarter And Half Year Ended September 30 2025.Nov 05, 2025
Investor PresentationSep 26, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementSep 26, 2025
Closure of Trading WindowSep 26, 2025
Voting Results Of The Annual General Meeting Held On 22Nd September 2025Sep 24, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 22, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 22, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 22, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 02, 2025
Newspaper AdvertisementAug 30, 2025
Business Responsibility and Sustainability Reporting (BRSR)Aug 29, 2025
Notice Of The 18Th Annual General Meeting ("AGM") (1St AGM Post Listing) Of The Company Is Scheduled To Be Held On Monday September 22 2025 At 17:00 Hrs IST Through Video Conferencing / Other Audio-Visual Means.Aug 29, 2025
Reg. 34 (1) Annual Report.Aug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 26, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2025
General UpdateAug 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 05, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 04, 2025
General UpdatesAug 04, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 04, 2025
Board Meeting Outcome for The Board Has Approved Standalone And Consolidated Financial Results For The Quarter Ended June 30 2025Aug 04, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJul 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 31, 2025
Board Meeting Intimation for Approval Of The Standalone And Consolidated Financial Results For The Quarter Ended June 30 2025Jul 29, 2025
General-UpdatesJul 15, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 07, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jul 07, 2025
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jul 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 01, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJun 30, 2025
Closure of Trading WindowJun 27, 2025
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jun 27, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 23, 2025
General-UpdatesJun 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 18, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Motilal Oswal Multi Cap Fund Direct - Growth
0.00%
-450000
-1.81%
-1.92%
Motilal Oswal Large and Midcap Fund Direct - Growth
2.49%
55001
-0.51%
-0.39%
Mirae Asset Healthcare Fund Direct - Growth
2.45%
37292
-0.26%
-0.30%
Mirae Asset Small Cap Fund Direct-Growth
1.51%
29629
-0.22%
-0.13%
Motilal Oswal Focused Fund Direct-Growth
3.47%
25362
-0.39%
-0.53%
Quant Small Cap Fund Direct Plan-Growth
0.00%
-16480
-0.01%
-0.24%
LIC MF Small Cap Fund Direct - Growth
1.23%
9572
0.08%
0.06%
JM Flexicap Fund Direct Plan-Growth
1.08%
-6879
-0.23%
-0.24%
LIC MF Aggressive Hybrid Fund Direct-Growth
1.00%
4639
-0.05%
0.27%
JM ELSS Tax Saver Fund Direct Plan-Growth
2.09%
3000
-0.24%
-0.34%
JM Focused Direct Plan-Growth
2.60%
2000
-0.42%
-0.23%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.43%
1413
-0.07%
-0.08%
LIC MF Flexi Cap Fund Direct-Growth
0.84%
1085
-0.16%
0.23%
LIC MF Healthcare Fund Direct - Growth
3.15%
743
-0.44%
0.55%
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.43%
683
-0.07%
-0.09%
Bandhan Midcap Fund Direct-Growth
0.35%
-559
-0.09%
-0.11%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth
0.42%
508
-0.07%
-0.09%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.42%
498
-0.08%
-0.09%
LIC MF Equity Savings Fund Direct-Growth
0.81%
377
-0.10%
0.14%
LIC MF Manufacturing Fund Direct-Growth
0.42%
-333
-0.06%
-0.06%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth
0.43%
294
-0.07%
-0.09%
SBI Nifty Smallcap 250 Index Fund Direct - Growth
0.43%
219
-0.07%
-0.08%
Motilal Oswal Nifty 500 Index Fund Direct - Growth
0.04%
217
-0.01%
-0.01%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.18%
184
-0.03%
-0.03%
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
0.43%
126
-0.07%
-0.03%

Technical Indicators

RSI(14)
Neutral
44.97
ATR(14)
Volatile
58.31
STOCH(9,6)
Neutral
36.97
STOCH RSI(14)
Neutral
60.03
MACD(12,26)
Bullish
4.03
ADX(14)
Weak Trend
14.98
UO(9)
Bearish
57.74
ROC(12)
Uptrend And Accelerating
0.45
WillR(14)
Neutral
-35.43